Furthermore, Gupta et al. demonstrated that targeted disruption of lipid rafts/Cav-1 or the mevalonic acid pathway reduced the invasiveness and metastatic potential of pancreatic cancer cells [49]. The gene discussed is CAV1; the disease is pancreatic neoplasm.